Cistanche flavonoids activate the Keap1-Nrf2-ARE signaling pathway in improving cognitive dysfunction in Alzheimer's disease: A review
Journal of Alzheimer’s Disease · 2025
DOI: 10.1177/13872877251361053 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Alzheimer’s Disease, 2025. Verfasst von Ruiqi Zhao und 7 weiteren Autor:innen. Beteiligte Einrichtung: Baotou Medical College, Baotou, Inner Mongolia, China. Hauptthemen laut MEDLINE: Alzheimer Disease, Signal Transduction, NF-E2-Related Factor 2, Flavonoids. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 72 Literaturangaben.
Themen: Demenz
Abstract (Originalsprache)
Alzheimer's disease (AD) is a progressive neurodegenerative disorder closely associated with oxidative stress, which plays a pivotal role in neuronal damage and disease progression. The Keap1-Nrf2-ARE signaling pathway plays a crucial role in regulating cellular responses to oxidative stress. Keap1 inhibits Nrf2 by maintaining its low expression, thus controlling antioxidant gene expression. Cistanche flavonoids, natural polyphenolic compounds, have been shown to activate this pathway. They suppress Keap1, preventing Nrf2 degradation and promoting its translocation to the nucleus, where it activates the antioxidant response element (ARE). This process significantly increases the production of antioxidant enzymes, such as superoxide dismutase and glutathione peroxidase. Elevated enzyme levels enhance cellular antioxidant defenses, reduce oxidative damage at the cellular and neuronal levels, and improve cognitive function in AD mouse models. The study examined the molecular composition of Cistanche flavonoids and their impact on the Keap1-Nrf2-ARE pathway, revealing their potential in mitigating AD-related changes. By neutralizing free radicals and enhancing antioxidant defenses, Cistanche flavonoids may offer a promising approach to counteract AD pathology. This comprehensive analysis underscores their therapeutic potential in alleviating AD through oxidative stress reduction and antioxidant activation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Baotou Medical College, Baotou, Inner Mongolia, China.
- School of Clinical Medicine, Tianjin Medical University, Tianjin, China.
Zitieren
APA
Zhao, R., Bai, W., Tian, Z., Li, X., Sun, R., Wang, Z., Yan, X., & Jia, J. (2025). Cistanche flavonoids activate the Keap1-Nrf2-ARE signaling pathway in improving cognitive dysfunction in Alzheimer's disease: A review. Journal of Alzheimer’s Disease. https://doi.org/10.1177/13872877251361053
Vancouver
Zhao R, Bai W, Tian Z, Li X, Sun R, Wang Z, et al. Cistanche flavonoids activate the Keap1-Nrf2-ARE signaling pathway in improving cognitive dysfunction in Alzheimer's disease: A review. Journal of Alzheimer’s Disease. 2025. doi:10.1177/13872877251361053
BibTeX
@article{Zhao2025,
author = {Zhao, Ruiqi and Bai, Wanfu and Tian, Zhenyu and Li, Xinye and Sun, Ruijun and Wang, Ziqi and Yan, Xusheng and Jia, Jianxin},
title = {Cistanche flavonoids activate the Keap1-Nrf2-ARE signaling pathway in improving cognitive dysfunction in Alzheimer's disease: A review},
journal = {Journal of Alzheimer’s Disease},
year = {2025},
doi = {10.1177/13872877251361053}
}
EUVIMED